Global Pre-Implantation Genetic Diagnosis (PGD) Market Research Report 2023

Report ID: 2006161 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Chromosomal Abnormalities
        1.2.3 X-linked Diseases
        1.2.4 Freeze Embryo Testing
        1.2.5 Aneuploidy Screening
        1.2.6 HLA
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Stem Cell Therapy
        1.3.3 IVF Prognosis
        1.3.4 Late-Onset Genetic Disorders
        1.3.5 Inherited Genetic Disease
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Perspective (2018-2029)
    2.2 Pre-Implantation Genetic Diagnosis (PGD) Growth Trends by Region
        2.2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Pre-Implantation Genetic Diagnosis (PGD) Historic Market Size by Region (2018-2023)
        2.2.3 Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Region (2024-2029)
    2.3 Pre-Implantation Genetic Diagnosis (PGD) Market Dynamics
        2.3.1 Pre-Implantation Genetic Diagnosis (PGD) Industry Trends
        2.3.2 Pre-Implantation Genetic Diagnosis (PGD) Market Drivers
        2.3.3 Pre-Implantation Genetic Diagnosis (PGD) Market Challenges
        2.3.4 Pre-Implantation Genetic Diagnosis (PGD) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Revenue
        3.1.1 Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Revenue (2018-2023)
        3.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Players (2018-2023)
    3.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Pre-Implantation Genetic Diagnosis (PGD) Revenue
    3.4 Global Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Ratio
        3.4.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Pre-Implantation Genetic Diagnosis (PGD) Revenue in 2022
    3.5 Pre-Implantation Genetic Diagnosis (PGD) Key Players Head office and Area Served
    3.6 Key Players Pre-Implantation Genetic Diagnosis (PGD) Product Solution and Service
    3.7 Date of Enter into Pre-Implantation Genetic Diagnosis (PGD) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Pre-Implantation Genetic Diagnosis (PGD) Breakdown Data by Type
    4.1 Global Pre-Implantation Genetic Diagnosis (PGD) Historic Market Size by Type (2018-2023)
    4.2 Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2024-2029)
5 Pre-Implantation Genetic Diagnosis (PGD) Breakdown Data by Application
    5.1 Global Pre-Implantation Genetic Diagnosis (PGD) Historic Market Size by Application (2018-2023)
    5.2 Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size (2018-2029)
    6.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2018-2023)
    6.4 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size (2018-2029)
    7.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2018-2023)
    7.4 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size (2018-2029)
    8.2 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2018-2023)
    8.4 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size (2018-2029)
    9.2 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2018-2023)
    9.4 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size (2018-2029)
    10.2 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2018-2023)
    10.4 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Detail
        11.1.2 Roche Business Overview
        11.1.3 Roche Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.1.4 Roche Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
        11.1.5 Roche Recent Development
    11.2 Genea Limited
        11.2.1 Genea Limited Company Detail
        11.2.2 Genea Limited Business Overview
        11.2.3 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.2.4 Genea Limited Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
        11.2.5 Genea Limited Recent Development
    11.3 Quest Diagnostics
        11.3.1 Quest Diagnostics Company Detail
        11.3.2 Quest Diagnostics Business Overview
        11.3.3 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.3.4 Quest Diagnostics Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
        11.3.5 Quest Diagnostics Recent Development
    11.4 Illumina, Inc.
        11.4.1 Illumina, Inc. Company Detail
        11.4.2 Illumina, Inc. Business Overview
        11.4.3 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.4.4 Illumina, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
        11.4.5 Illumina, Inc. Recent Development
    11.5 Natera, Inc.
        11.5.1 Natera, Inc. Company Detail
        11.5.2 Natera, Inc. Business Overview
        11.5.3 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.5.4 Natera, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
        11.5.5 Natera, Inc. Recent Development
    11.6 Cooper Medical, Inc.
        11.6.1 Cooper Medical, Inc. Company Detail
        11.6.2 Cooper Medical, Inc. Business Overview
        11.6.3 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.6.4 Cooper Medical, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
        11.6.5 Cooper Medical, Inc. Recent Development
    11.7 LabCorp
        11.7.1 LabCorp Company Detail
        11.7.2 LabCorp Business Overview
        11.7.3 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.7.4 LabCorp Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
        11.7.5 LabCorp Recent Development
    11.8 California Pacific Medical Center (CPMC)
        11.8.1 California Pacific Medical Center (CPMC) Company Detail
        11.8.2 California Pacific Medical Center (CPMC) Business Overview
        11.8.3 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.8.4 California Pacific Medical Center (CPMC) Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
        11.8.5 California Pacific Medical Center (CPMC) Recent Development
    11.9 Thermo Fisher Scientific Inc.
        11.9.1 Thermo Fisher Scientific Inc. Company Detail
        11.9.2 Thermo Fisher Scientific Inc. Business Overview
        11.9.3 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.9.4 Thermo Fisher Scientific Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
        11.9.5 Thermo Fisher Scientific Inc. Recent Development
    11.10 IGENOMIX
        11.10.1 IGENOMIX Company Detail
        11.10.2 IGENOMIX Business Overview
        11.10.3 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.10.4 IGENOMIX Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
        11.10.5 IGENOMIX Recent Development
    11.11 Reproductive Genetic Innovations
        11.11.1 Reproductive Genetic Innovations Company Detail
        11.11.2 Reproductive Genetic Innovations Business Overview
        11.11.3 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.11.4 Reproductive Genetic Innovations Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
        11.11.5 Reproductive Genetic Innovations Recent Development
    11.12 CombiMatrix
        11.12.1 CombiMatrix Company Detail
        11.12.2 CombiMatrix Business Overview
        11.12.3 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.12.4 CombiMatrix Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
        11.12.5 CombiMatrix Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Chromosomal Abnormalities
    Table 3. Key Players of X-linked Diseases
    Table 4. Key Players of Freeze Embryo Testing
    Table 5. Key Players of Aneuploidy Screening
    Table 6. Key Players of HLA
    Table 7. Key Players of Others
    Table 8. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 10. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2018-2023) & (US$ Million)
    Table 11. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Region (2018-2023)
    Table 12. Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 13. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Region (2024-2029)
    Table 14. Pre-Implantation Genetic Diagnosis (PGD) Market Trends
    Table 15. Pre-Implantation Genetic Diagnosis (PGD) Market Drivers
    Table 16. Pre-Implantation Genetic Diagnosis (PGD) Market Challenges
    Table 17. Pre-Implantation Genetic Diagnosis (PGD) Market Restraints
    Table 18. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue by Players (2018-2023) & (US$ Million)
    Table 19. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Players (2018-2023)
    Table 20. Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pre-Implantation Genetic Diagnosis (PGD) as of 2022)
    Table 21. Ranking of Global Top Pre-Implantation Genetic Diagnosis (PGD) Companies by Revenue (US$ Million) in 2022
    Table 22. Global 5 Largest Players Market Share by Pre-Implantation Genetic Diagnosis (PGD) Revenue (CR5 and HHI) & (2018-2023)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Pre-Implantation Genetic Diagnosis (PGD) Product Solution and Service
    Table 25. Date of Enter into Pre-Implantation Genetic Diagnosis (PGD) Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2018-2023) & (US$ Million)
    Table 28. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2018-2023)
    Table 29. Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 30. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2024-2029)
    Table 31. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2018-2023) & (US$ Million)
    Table 32. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Application (2018-2023)
    Table 33. Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 34. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Application (2024-2029)
    Table 35. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2018-2023) & (US$ Million)
    Table 37. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2018-2023) & (US$ Million)
    Table 40. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2024-2029) & (US$ Million)
    Table 41. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2018-2023) & (US$ Million)
    Table 43. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2024-2029) & (US$ Million)
    Table 44. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 48. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2024-2029) & (US$ Million)
    Table 50. Roche Company Detail
    Table 51. Roche Business Overview
    Table 52. Roche Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 53. Roche Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
    Table 54. Roche Recent Development
    Table 55. Genea Limited Company Detail
    Table 56. Genea Limited Business Overview
    Table 57. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 58. Genea Limited Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
    Table 59. Genea Limited Recent Development
    Table 60. Quest Diagnostics Company Detail
    Table 61. Quest Diagnostics Business Overview
    Table 62. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 63. Quest Diagnostics Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
    Table 64. Quest Diagnostics Recent Development
    Table 65. Illumina, Inc. Company Detail
    Table 66. Illumina, Inc. Business Overview
    Table 67. Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 68. Illumina, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
    Table 69. Illumina, Inc. Recent Development
    Table 70. Natera, Inc. Company Detail
    Table 71. Natera, Inc. Business Overview
    Table 72. Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 73. Natera, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
    Table 74. Natera, Inc. Recent Development
    Table 75. Cooper Medical, Inc. Company Detail
    Table 76. Cooper Medical, Inc. Business Overview
    Table 77. Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 78. Cooper Medical, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
    Table 79. Cooper Medical, Inc. Recent Development
    Table 80. LabCorp Company Detail
    Table 81. LabCorp Business Overview
    Table 82. LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 83. LabCorp Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
    Table 84. LabCorp Recent Development
    Table 85. California Pacific Medical Center (CPMC) Company Detail
    Table 86. California Pacific Medical Center (CPMC) Business Overview
    Table 87. California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 88. California Pacific Medical Center (CPMC) Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
    Table 89. California Pacific Medical Center (CPMC) Recent Development
    Table 90. Thermo Fisher Scientific Inc. Company Detail
    Table 91. Thermo Fisher Scientific Inc. Business Overview
    Table 92. Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 93. Thermo Fisher Scientific Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
    Table 94. Thermo Fisher Scientific Inc. Recent Development
    Table 95. IGENOMIX Company Detail
    Table 96. IGENOMIX Business Overview
    Table 97. IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 98. IGENOMIX Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
    Table 99. IGENOMIX Recent Development
    Table 100. Reproductive Genetic Innovations Company Detail
    Table 101. Reproductive Genetic Innovations Business Overview
    Table 102. Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 103. Reproductive Genetic Innovations Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
    Table 104. Reproductive Genetic Innovations Recent Development
    Table 105. CombiMatrix Company Detail
    Table 106. CombiMatrix Business Overview
    Table 107. CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 108. CombiMatrix Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023) & (US$ Million)
    Table 109. CombiMatrix Recent Development
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type: 2022 VS 2029
    Figure 3. Chromosomal Abnormalities Features
    Figure 4. X-linked Diseases Features
    Figure 5. Freeze Embryo Testing Features
    Figure 6. Aneuploidy Screening Features
    Figure 7. HLA Features
    Figure 8. Others Features
    Figure 9. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 10. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application: 2022 VS 2029
    Figure 11. Stem Cell Therapy Case Studies
    Figure 12. IVF Prognosis Case Studies
    Figure 13. Late-Onset Genetic Disorders Case Studies
    Figure 14. Inherited Genetic Disease Case Studies
    Figure 15. Others Case Studies
    Figure 16. Pre-Implantation Genetic Diagnosis (PGD) Report Years Considered
    Figure 17. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 18. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 19. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Region: 2022 VS 2029
    Figure 20. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Players in 2022
    Figure 21. Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pre-Implantation Genetic Diagnosis (PGD) as of 2022)
    Figure 22. The Top 10 and 5 Players Market Share by Pre-Implantation Genetic Diagnosis (PGD) Revenue in 2022
    Figure 23. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. North America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Country (2018-2029)
    Figure 25. United States Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Canada Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Share by Country (2018-2029)
    Figure 29. Germany Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. France Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. U.K. Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Italy Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Russia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Nordic Countries Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Share by Region (2018-2029)
    Figure 37. China Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. South Korea Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. India Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Australia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Country (2018-2029)
    Figure 45. Mexico Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Brazil Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Share by Country (2018-2029)
    Figure 49. Turkey Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 50. Saudi Arabia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 51. Roche Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
    Figure 52. Genea Limited Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
    Figure 53. Quest Diagnostics Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
    Figure 54. Illumina, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
    Figure 55. Natera, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
    Figure 56. Cooper Medical, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
    Figure 57. LabCorp Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
    Figure 58. California Pacific Medical Center (CPMC) Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
    Figure 59. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
    Figure 60. IGENOMIX Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
    Figure 61. Reproductive Genetic Innovations Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
    Figure 62. CombiMatrix Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2018-2023)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Genea Limited
Quest Diagnostics
Illumina, Inc.
Natera, Inc.
Cooper Medical, Inc.
LabCorp
California Pacific Medical Center (CPMC)
Thermo Fisher Scientific Inc.
IGENOMIX
Reproductive Genetic Innovations
CombiMatrix
Frequently Asked Questions
Pre-Implantation Genetic Diagnosis (PGD) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pre-Implantation Genetic Diagnosis (PGD) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pre-Implantation Genetic Diagnosis (PGD) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Women’s Health App

This report aims to provide a comprehensive presentation of the global market for Women’s Healt ... Read More